May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Transforming Growth Factor-b2 Inhibition of Corneal Endothelial Proliferation Mediated by Prostaglandin E2
Author Affiliations & Notes
  • K. Chen
    Ophthalmology, Veterans General Hospital-Taipei, Taipei, Taiwan Republic of China
  • W. Hsu
    Ophthalmology, Veterans General Hospital-Taipei, Taipei, Taiwan Republic of China
  • C. Chiang
    Ophthalmology, Veterans General Hospital-Taipei, Taipei, Taiwan Republic of China
  • Y. Li
    Ophthalmology, Veterans General Hospital-Taipei, Taipei, Taiwan Republic of China
  • Footnotes
    Commercial Relationships  K. Chen, None; W. Hsu, None; C. Chiang, None; Y. Li, None.
  • Footnotes
    Support  Nil
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 4737. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. Chen, W. Hsu, C. Chiang, Y. Li; Transforming Growth Factor-b2 Inhibition of Corneal Endothelial Proliferation Mediated by Prostaglandin E2 . Invest. Ophthalmol. Vis. Sci. 2003;44(13):4737.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To investigate the role of prostaglandin (PG) E2 synthesis in mediating the inhibitory effect of transforming growth factor (TGF)-b2 on corneal endothelial (CE) proliferation. Methods: The PGE2 and cell proliferation assays were performed using cultured rabbit corneal endothelium. A PGE2-specific enzyme immunoassay was used to check PGE2 synthesis in supernatants of cells cultured with and without added TGF-b2 and/or indomethacin. To evaluate the inhibitory effects of PGE2 and TGF-b2 on CE proliferation, the number of cells grown with exogenous PGE2, or TGF-b2 with or without indomethacin pretreatment was determined. Results: TGF-b2, 0.5 to 50 ng/ml, increased the PGE2 secretion of CE dose-dependently in a time-dependent manner. Indomethacin (3 0.1 mg/ml) inhibited this PGE2 secretion to a low level (around 5-10 ng/ml) in the presence or absence of exogenous TGF-b2. Both exogenous TGF-b2 and PGE2 inhibited CE proliferation dose-dependently over a wide range of concentrations. Indomethacin reversed the inhibitory effects of TGF-b2 but not those of exogenous PGE2. In the medium supplemented with indomethacin, even in the presence of 50 ng/ml of TGF-b2, CE growth did not differ from control cultures. Conclusions: TGF-b2 stimulates PGE2 synthesis in CE and dose-dependently inhibits CE proliferation. Indomethacin extinguishes the inhibitory effects of TGF-b2 on CE proliferation but not the effect of exogenous PGE2. These data suggest that the antiproliferative effects of TGF-b2 on CE may be due to TGF-b2-induced synthesis of autocrine PGE2.

Keywords: cornea: endothelium • cornea: basic science • cytokines/chemokines 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×